颅内动脉瘤市场规模、份额和成长分析（按产品类型、最终用户和地区）- 产业预测，2025-2032 年

Intracranial Aneurysm Market Size, Share, Growth Analysis, By Product Type (Aneurysm Therapeutic Devices, Embolization Devices), By Type (Saccular aneurysm, Fusiform aneurysm), By End-User, By Region - Industry Forecast 2025-2032

出版日期: 2025年01月14日 | 出版商:

SkyQuest | 英文 236 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2023 年全球颅内动脉瘤市场规模价值为 13 亿美元，预计将从 2024 年的 14.2 亿美元成长到 2032 年的 28.2 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.0%。

受人口老化、早期诊断和早期疗育意识的增强以及医疗技术的强劲进步的推动，全球颅内动脉瘤市场预计将持续成长。已开发市场和新兴市场的医疗保健支出不断增加，扩大了获得基本服务的机会，特别是在颅内动脉瘤的诊断和治疗方面。盘管固定和血流改道等微创血管内治疗方法的兴起因其风险较低、住院时间较短、恢復时间缩短而受到关注。此外，影像技术的改进使得检测和治疗计划更加准确。然而，治疗费用高、血管内治疗复杂等挑战可能会阻碍市场扩张。随着意识和技术的不断进步，解决这些障碍对于最大限度地发挥市场潜力至关重要。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲国家
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前 5 家公司对比
主要企业市场定位（2024年）
主要市场参与者所采用的策略
近期市场趋势
公司市场占有率分析（2024 年）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分析市场份额
- 收益与前一年同期比较（2022-2024 年）

主要企业简介

Medtronic plc（Ireland）
Stryker Corporation（United States）
MicroPort Scientific Corporation（China）
Johnson & Johnson Services, Inc.（United States）
MicroVention Inc.（United States）
B. Braun Melsungen AG（Germany）
Integra LifeSciences（United States）
RAUMEDIC AG（Germany）
Terumo Corporation（Japan）
Delta Surgical（United Kingdom）
MicroVention Terumo（United States）
Penumbra, Inc.（United States）
Balt USA（United States）
Phenox GmbH（Germany）
InspireMD, Inc.（Israel）
Kaneka Medix Corporation（Japan）
Evasc Neurovascular Enterprises ULC（Canada）

结论和建议

简介目录

Product Code: SQMIG35A2427

Global Intracranial Aneurysm Market size was valued at USD 1.3 billion in 2023 and is poised to grow from USD 1.42 billion in 2024 to USD 2.82 billion by 2032, growing at a CAGR of 9.0% during the forecast period (2025-2032).

The global intracranial aneurysm market is poised for sustained growth, fueled by an aging population, heightened awareness around early diagnosis and intervention, and robust advancements in medical technology. Increased healthcare spending in both developed and emerging markets has broadened access to essential services, particularly in diagnosing and treating intracranial aneurysms. The rise of minimally invasive endovascular techniques, like coiling and flow diversion, has garnered attention due to their lower risk profiles, reduced hospital stays, and improved recovery times. Additionally, enhanced imaging technologies have enabled more accurate detection and treatment planning. However, challenges such as high treatment costs and the complexities of endovascular procedures may hinder market expansion. As awareness and technology continue to advance, addressing these barriers will be crucial for maximizing market potential.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intracranial Aneurysm market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intracranial Aneurysm Market Segmental Analysis

Global Intracranial Aneurysm Market is segmented by Product Type, Type, End-User and region. Based on Product Type, the market is segmented into Aneurysm Therapeutic Devices, Embolization Devices, Aspiration Devices and Access Devices. Based on Type, the market is segmented into Saccular aneurysm, Fusiform aneurysm and Mycotic aneurysm. Based on End-User, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Intracranial Aneurysm Market

The global market for intracranial aneurysms is primarily driven by significant technological advancements in the medical field. Innovations such as minimally invasive endovascular procedures, enhanced imaging techniques, and the introduction of cutting-edge devices are pivotal in fostering market expansion. These developments not only improve treatment efficacy but also contribute to enhanced patient experiences by minimizing discomfort and expediting recovery periods. As healthcare professionals adopt these advanced technologies, the overall quality of care for patients with intracranial aneurysms is expected to improve, further propelling growth in this market segment.

Restraints in the Global Intracranial Aneurysm Market

The global market for intracranial aneurysms faces significant constraints due to exorbitant treatment costs. Patients requiring intervention for these conditions often encounter substantial expenses, particularly in cases that involve complex procedures or advanced medical devices. This financial burden can create barriers to accessing necessary care for some individuals and potentially lead to disparities in treatment options. Additionally, the high costs can place considerable strain on healthcare systems, affecting their ability to provide comprehensive care for all patients suffering from intracranial aneurysms. Ultimately, these economic factors can hinder overall market growth and patient outcomes in this critical area of healthcare.

Market Trends of the Global Intracranial Aneurysm Market

The Global Intracranial Aneurysm market is witnessing a significant shift towards minimally invasive procedures, driven by advancements in endovascular techniques such as coiling and flow diversion. These methods are increasingly favored for their lower invasiveness, shorter recovery times, and improved patient outcomes compared to traditional open surgical interventions. As healthcare providers and patients prioritize safety and efficiency, the demand for these innovative treatments continues to surge, leading to enhanced market growth. This trend not only reflects broader healthcare advancements but also underscores the imperative for ongoing research and development in neurovascular therapies, positioning the market for sustained expansion in the coming years.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Intracranial Aneurysm Market Size by Product Type & CAGR (2025-2032)

Market Overview
Aneurysm Therapeutic Devices
- Clips
- Coils
- Intravascular Devices
- Flow Diverter
Embolization Devices
- Occlusion Catheters
- Embolic Agent
Aspiration Devices
- Aspiration Catheter
- Clot Retrieval Device
Access Devices
- Micro Catheter
- Guidewire

Global Intracranial Aneurysm Market Size by Type & CAGR (2025-2032)

Market Overview
Saccular aneurysm
Fusiform aneurysm
Mycotic aneurysm

Global Intracranial Aneurysm Market Size by End-User & CAGR (2025-2032)

Market Overview
Hospitals
Specialty Clinics
Others

Global Intracranial Aneurysm Market Size & CAGR (2025-2032)

North America (Product Type, Type, End-User)
- US
- Canada
Europe (Product Type, Type, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product Type, Type, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product Type, Type, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product Type, Type, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson Services, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVention Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RAUMEDIC AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Delta Surgical (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroVention Terumo (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Balt USA (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Phenox GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
InspireMD, Inc. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaneka Medix Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Evasc Neurovascular Enterprises ULC (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments